• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Acuson expands line with less expensive unit

Article

Acuson will introduce a relatively inexpensive ultrasound scannersans color-flow Doppler at the American Institute of Ultrasoundin Medicine meeting in Atlanta this week. The move does not signalAcuson's intention to become a mid- and low-tier ultrasound

Acuson will introduce a relatively inexpensive ultrasound scannersans color-flow Doppler at the American Institute of Ultrasoundin Medicine meeting in Atlanta this week. The move does not signalAcuson's intention to become a mid- and low-tier ultrasound manufacturer,however, according to Clay Larsen, radiology marketing manager.

"We see an increasing need for high-performance, black-and-white-onlysystems in the marketplace. We have heard this from our customersand are filling a market need that is out there," he toldSCAN. "If this expands our opportunities into other markets--sayperinatology or obstetrics--that is an upside opportunity. Certainly,this is not a mid-range, office-type system."

The 128 XP3 will sell in the range of $90,000 to $120,000,compared to the XP10, which hovers around $200,000. Acuson maintainedwhen the XP system was released in July that it is more configurablethan the vendor's previous platform. System configurability allowsfor the introduction of a variety of scanner mainframes basedon the same basic 128-channel platform, he said.

"It (the XP) has increased our ability to react wherewe see demands in the marketplace--and not only upward,"Larsen said. "It is still a premium-performance system, butit is for people who want high performance but can't justify theextra cost for color and other options."

The XP3 does not include vector-array technology that was introducedwith the XP10. It does have sector scanning, however, he said.

The primary use of the XP3 is expected to be as a second systemfor radiology departments in need of extra capacity.

"Instead of buying a different system than the one theirsonographers are familiar with, many Acuson customers would appreciatehaving the Acuson performance (in a lower cost second scanner).They can also share transducers between systems," Larsensaid.

It is also likely that obstetricians, urologists and otherprivate-practice physicians may seize the opportunity to buy ahospital-grade ultrasound system for less money. Many privateoffices, pressed by competition for referrals, would like to owna higher performance scanner but can't justify an $80,000 pricedifferential, he said.

"The desire for hospital-grade equipment has always beenthere, but now it is going to be somewhat more within the reachof private offices," Larsen said.

Expanding into mid-tier scanners might help Acuson competeagainst competitors such as Toshiba, particularly in internationalmarkets. The high-end ultrasound leader wants to keep its qualityreputation, however.

"There is still tremendous growth opportunity in the hospital-grade,premium-performance line of equipment, both in the U.S. and internationally,"Larsen said.

Recent Videos
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 2
Related Content
© 2025 MJH Life Sciences

All rights reserved.